Provided by Tiger Trade Technology Pte. Ltd.

Keros Therapeutics, Inc.

11.02
+0.03000.27%
Post-market: 11.020.00000.00%16:20 EDT
Volume:516.58K
Turnover:5.71M
Market Cap:217.29M
PE:4.79
High:11.35
Open:11.02
Low:10.88
Close:10.99
52wk High:22.55
52wk Low:9.12
Shares:19.72M
Float Shares:9.88M
Volume Ratio:0.78
T/O Rate:5.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.30
EPS(LYR):2.30
ROE:19.90%
ROA:9.25%
PB:0.72
PE(LYR):4.79

Loading ...

Keros Therapeutics CEO Jasbir S. Seehra Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Reuters
·
Feb 19

Keros Therapeutics Highlights Rinvatercept Strategy in Updated Presentation

TIPRANKS
·
Jan 10

Keros Therapeutics (KROS): Valuation Check After Sharp Share Price Rebound and Ongoing Revenue Contraction Forecasts

Simply Wall St.
·
Dec 08, 2025

BRIEF-Keros Therapeutics Announces Final Results Of Tender Offer

Reuters
·
Nov 21, 2025

Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer

MT Newswires Live
·
Nov 19, 2025

Keros Therapeutics Inc - Announces Tender Offer to Repurchase Common Shares for $194.4 Mln

THOMSON REUTERS
·
Nov 19, 2025

Keros Therapeutics Inc. : Oppenheimer Raises Target Price to $27 From $23

THOMSON REUTERS
·
Nov 12, 2025

Biopharma company Keros' Q3 net loss narrows on Takeda license revenue

Reuters
·
Nov 06, 2025

Keros Therapeutics reports third quarter net loss of $7.3 million

Reuters
·
Nov 06, 2025

Keros Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview

Reuters
·
Nov 01, 2025

Keros Initiates Share Repurchase Program of Up to $194.4 Million

Deep News
·
Oct 20, 2025

Keros Therapeutics to repurchase $194.4M of shares

TIPRANKS
·
Oct 20, 2025

Keros Therapeutics Inc - Expects to Fund Tender Offer From Its Existing Cash and Cash Equivalents

THOMSON REUTERS
·
Oct 20, 2025

Pontifax Management 4 G.P. (2015) Ltd. Reports Disposal of Keros Therapeutics Inc. Common Shares

Reuters
·
Oct 18, 2025

Major Shareholder Sells Millions in Keros Therapeutics Stock!

TIPRANKS
·
Oct 16, 2025

ADAR1 Capital Management, LLC Reports Disposal of Common Shares of Keros Therapeutics Inc

Reuters
·
Oct 16, 2025

Keros Therapeutics Inc - Aggregate Purchase Price for Repurchase Is $181 Mln

THOMSON REUTERS
·
Oct 15, 2025

Keros Therapeutics Inc - to Distribute 25% of Takeda Proceeds to Stockholders

THOMSON REUTERS
·
Oct 15, 2025

Keros Therapeutics Inc - Intends to Commence Tender Offer for $194 Mln in Shares

THOMSON REUTERS
·
Oct 15, 2025

Press Release: Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital

Dow Jones
·
Oct 15, 2025